Price and states served both move. Read them off the seller's own site before you enroll.How our reviews work →

Gala vs Näky

Näky costs $4 less a month, and both sell semaglutide and tirzepatide.

Some of the links on this page earn us money. If you sign up with a provider after following one, that provider may pay GLP Watchdog a commission. Learn more

By Ruth Calder · Enforcement Editor
Editorially reviewed (not clinically reviewed). Not medical advice · How we verify contentLast reviewed
Gala logo

Gala

8.7
★★★★☆4.4/5

Best for: moving between compounded and brand without changing seller

Visit Gala →
VS
Näky logo

Näky

6.3
★★★☆☆3.2/5
Visit Näky →

If you are choosing between Gala and Näky, the first difference is cost: Näky is $4 a month cheaper at the entry price. Both prescribe semaglutide and tirzepatide, so moving from one to the other would not change your drug. Gala leads our six-part score, 8.7 to 6.3.

Gala vs Näky price

Näky is the cheaper way in: $145 a month against $149 a month at Gala. That is $4 less each month (3% lower), or about $48 over a year of treatment.

Drug by drug: Semaglutide is cheaper at Näky ($145 a month vs $179 a month); tirzepatide is cheaper at Gala ($149 a month vs $295 a month).

Medications and formats

Both sell semaglutide and tirzepatide.

On format they match: each offers compounded injections and brand-name pens.

Where each one treats patients

Gala lists 50 states, and Näky does not publish where it ships.

Pricing

Gala

Compounded GLP-1 (all doses)Compounded
$179$129/mo
Save 28% right now
semaglutide

$179/mo on a yearly subscription, all doses included. Gala's FAQ says 'starting at just $199 per month (with a 3-month plan).' A promo page offers 'starting at $129/month with $120 off your first shipment' on monthly, 3-, 6- and 12-month plans. Exact plan prices appear only after the intake questionnaire.

Compounded GLP-1/GIP (all doses)Compounded
$179/mo
tirzepatide

$179/month on a yearly subscription, all doses included; the $120-off-first-shipment promo applies. Tirzepatide plan prices are shown only after intake.

Microdosing GLP-1/GIPCompounded
$149/mo
tirzepatide

$149/month, yearly subscription; 'Low-dose GLP-1/GIP for sustained energy, sleep and metabolic balance.'

Ozempic (brand)Brand-name
$1299/mo
semaglutide

'Ozempic® Brand-name semaglutide $1,299/month' — unchanged. Wegovy pill still 'Coming soon / Pricing at launch' (not a priced row).

Näky

Weekly injection — 1-month supplyCompounded
$185/mo
semaglutide
Weekly injection — 1-month supplyCompounded
$295/mo
tirzepatide
Daily oral drops — monthly onlyCompounded
$145/mo
semaglutide
Wegovy® Pill — maintenance dose, all-inBrand-name
$424/mo
semaglutide

What each price covers

Both prices cover shipping.

Gala's price also covers the clinician visit and the medication itself, which Näky does not claim.

Gala is silent on lab work and coaching.

Näky is silent on the clinician visit, the medication itself, lab work and coaching.

That matters most for the drug: unless Näky confirms otherwise, budget for medication on top of its listed price.

Gala

Covered by the monthly price

Medication

In the price

Clinician visits

In the price

Shipping

In the price

Lab work

Not stated

Coaching

Not stated

Näky

Covered by the monthly price

Medication

Not stated

Clinician visits

Not stated

Shipping

In the price

Lab work

Not stated

Coaching

Not stated

Where each one scores higher

Overall, Gala scores 8.7 and Näky 6.3 out of 10.

Gala is stronger on value (8.7 vs 6.8), user experience (8.0 vs 3.0), trust & safety (7.5 vs 4.0), accessibility (10.0 vs 5.0) and support (7.0 vs 5.0).

Effectiveness is within half a point.

How we score

Gala

8.7/10

Overall

Näky

6.3/10

Value25%

8.7A
vs
B
6.8

Effectiveness25%

10.0A
vs
B
10.0

User Experience15%

8.0A
vs
B
3.0

Trust & Safety15%

7.5A
vs
B
4.0

Accessibility10%

10.0A
vs
B
5.0

Support10%

7.0A
vs
B
5.0

FDA warning letters

Neither Gala nor Näky has an FDA warning letter on record with us.

Features & Coverage

FeatureGalaNäky
Starting Price$149/mo✓$145/mo
Features7 features✓8 features
States Available50Not disclosed
Compounded✓ Yes✓ Yes
Brand Name✓ Yes✓ Yes
FSA/HSA Accepted——
FDA Warning LettersNoneNone

About Gala

A yearly subscription is the format: compounded semaglutide and compounded tirzepatide are sold that way, with a cheaper microdosing program beside them and brand-name Ozempic on the same menu. The corporate name is AI Coaching Inc., which does business as Gala GLP-1 and is incorporated in Delaware. Providers licensed in every one of the 50 states, plus shipping at no cost, are what the marketing site claims. A Wegovy pill taken orally is flagged as coming soon.

Read our full Gala review →

About Näky

Pricing at steady state stays behind the intake. Näky holds LegitScript approval and sells compounded semaglutide and compounded tirzepatide, adds an oral semaglutide drops product that few others carry, runs a GLP-1 microdose program separately, and offers NAD+ and Sermorelin on top. Getting started means a 3-minute assessment online, after which a licensed provider returns a treatment plan the same day. For the oral line a NAKY10 promo code is referenced.

Read our full Näky review →

Pros & Cons

Gala

What we like

  • Semaglutide costs $179 a month, close to the $185 median for compounded semaglutide across the sellers we compare
  • Tirzepatide costs $149 a month, 40% below the $250 median for compounded tirzepatide across the sellers we compare
  • Shows its price before the medical questionnaire, so you can compare it without handing over health information
  • The monthly price stays the same as your dose goes up
  • The monthly price includes the medication, clinician visits and shipping
  • Serves all 50 states
  • We found no FDA warning letters issued to Gala

Watch-outs

  • Ask which pharmacy fills the prescription before you pay, so you can check its license
  • Its semaglutide and tirzepatide are compounded rather than FDA-approved, so they have not been reviewed by the agency for safety, effectiveness or manufacturing quality

Näky

What we like

  • Semaglutide costs $145 a month, 22% below the $185 median for compounded semaglutide across the sellers we compare
  • The monthly price stays the same as your dose goes up
  • The monthly price includes shipping
  • We found no FDA warning letters issued to Näky

Watch-outs

  • Tirzepatide costs $295 a month, 18% above the $250 median for compounded tirzepatide across the sellers we compare
  • You only see a price after finishing the medical intake, so you cannot compare costs before sharing health information
  • Confirm it serves your state before you start the intake
  • Ask which pharmacy fills the prescription before you pay, so you can check its license
  • Its semaglutide and tirzepatide are compounded rather than FDA-approved, so they have not been reviewed by the agency for safety, effectiveness or manufacturing quality

Our Verdict

Winner: Gala

Gala wins this one, 8.7 to 6.3, above all for moving between compounded and brand without changing seller. Näky undercuts it by $4 a month, so if the monthly bill is what decides it, Näky is the pick.

Choose Gala if…

You want moving between compounded and brand without changing seller and an opening price near $149 a month.

Choose Näky if…

You want the lower starting price and an opening price near $145 a month.

Ready to start? GLP-1 providers we have vetted

Telehealth providers, vetted by us, prescribing GLP-1 online.

Vetted by our editors · no insurance required

Some of the links on this page earn us money. If you sign up with a provider after following one, that provider may pay GLP Watchdog a commission. Learn more

9.3

Embody

Knowing which pharmacy fills the vial: it names RedRock Pharmacy

8.2

YourEra

Semaglutide at $99/month, 63% below the typical price

8.7

Gala

Moving between compounded and brand without changing seller

Gala vs Näky: FAQ

Näky. It starts at $145 a month; Gala starts at $149 a month, $4 more per month.
Yes, both sell semaglutide and tirzepatide.
Gala lists 50 states; Näky does not publish where it ships. Confirm your state before paying.
Both include shipping. Only Gala includes the clinician visit and the medication itself.
Gala has none. Näky has none.
Gala pays us a commission on sign-ups through our links; Näky does not. Scores are computed the same way for both.

Or see the full category ranking.

Novo Nordisk A/S owns the Wegovy®, Ozempic® and Rybelsus® marks; Eli Lilly and Company owns Mounjaro® and Zepbound®. Every other product name and mark on this page belongs to whoever owns it. No pharmaceutical manufacturer is affiliated with GLP Watchdog. See trademark disclaimer.